var data={"title":"The genodermatoses","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">The genodermatoses</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/the-genodermatoses/contributors\" class=\"contributor contributor_credentials\">Teresa S Wright, MD, FAAD, FAAP</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/the-genodermatoses/contributors\" class=\"contributor contributor_credentials\">Helen V Firth, DM, FRCP, DCH</a></dd><dd><a href=\"https://www.uptodate.com/contents/the-genodermatoses/contributors\" class=\"contributor contributor_credentials\">Jennifer L Hand, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/the-genodermatoses/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/the-genodermatoses/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 08, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An overview of the most commonly encountered inherited skin diseases is presented here. A few rarer disorders are also reviewed because of particular clinical importance in their pathogenesis or treatment. Internet resources that include information about these disorders include <a href=\"http://www.orpha.net/consor/cgi-bin/index.php&amp;token=4hC9Pn3gU02P3vhmB5SRkyk3NWJryHOwntvDgII6uPCwtPl2S6XDsLxsw0r20Jy/CdT+6Zdl9t9A2nXXQu0l0Q==&amp;TOPIC_ID=3004\" target=\"_blank\" class=\"external\">Orphanet</a> and <a href=\"http://www.omim.org/&amp;token=G+kOOgscg7PQzd0gXq5S9x/zLM1otKVlXe08jt6KdIg=&amp;TOPIC_ID=3004\" target=\"_blank\" class=\"external\">Mendelian Inheritance in Man (OMIM)</a>.</p><p class=\"headingAnchor\" id=\"H523750729\"><span class=\"h1\">OVERVIEW</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The genodermatoses are a large group of inherited single-gene disorders with skin manifestations. Many of these disorders are rare. However, the recognition of their skin findings is important not only for the initiation of appropriate dermatologic therapy, but also for the detection of other associated abnormalities in these frequently multisystem disorders, including malignancy [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/1-3\" class=\"abstract_t\">1-3</a>].</p><p class=\"headingAnchor\" id=\"H523750890\"><span class=\"h1\">DISORDERS WITH MALIGNANT POTENTIAL</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>This group of genodermatoses is of particular importance because of the association of skin findings with the development of malignancies, both cutaneous and noncutaneous (<a href=\"image.htm?imageKey=PEDS%2F72060\" class=\"graphic graphic_table graphicRef72060 \">table 1</a>). Examples include basal cell nevus syndrome, Gardner syndrome, Peutz-Jeghers syndrome (PJS), and Xeroderma pigmentosum (XP).</p><p class=\"headingAnchor\" id=\"H523750943\"><span class=\"h2\">Basal cell nevus syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The basal cell nevus syndrome (nevoid basal cell carcinoma syndrome, Gorlin syndrome, MIM #109400) is a rare disorder of autosomal dominant inheritance that results from germline mutations of the human patched gene (<em>PTCH</em>). (See <a href=\"topic.htm?path=nevoid-basal-cell-carcinoma-syndrome\" class=\"medical medical_review\">&quot;Nevoid basal cell carcinoma syndrome&quot;</a>.)</p><p>Affected patients have both developmental anomalies and postnatal tumors, especially multiple basal cell carcinomas (BCCs), usually by age 35 years. Most have the following clinical features:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Macrocephaly, frontal bossing, and hypertelorism</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bifid ribs</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Palmar and plantar pitting (<a href=\"image.htm?imageKey=ONC%2F72687\" class=\"graphic graphic_picture graphicRef72687 \">picture 1</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Odontogenic keratocysts, especially in the mandible, which usually develop in adolescence and typically are the presenting sign of the disorder</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Medulloblastoma in 3 to 5 percent; meningioma occurs infrequently (see <a href=\"topic.htm?path=epidemiology-pathogenesis-and-clinical-features-of-basal-cell-carcinoma\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, and clinical features of basal cell carcinoma&quot;</a>)</p><p/><p>The histologic appearance of the BCCs in basal cell nevus syndrome does not differ from those seen in sporadic cases. The diagnosis should be suspected in patients who present with multiple BCCs, especially at an early age.</p><p>These patients require careful sun protection from infancy and regular skin surveillance by a dermatologist. Radiotherapy should be avoided due to the risk of inducing BCCs in the treatment fields.</p><p class=\"headingAnchor\" id=\"H523750950\"><span class=\"h2\">Gardner syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gardner syndrome consists of familial adenomatous polyposis (FAP, MIM #175100) with associated extraintestinal manifestations [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/4\" class=\"abstract_t\">4</a>]. It is inherited as an autosomal dominant disorder caused by mutations in the tumor suppressor gene, adenomatous polyposis coli (<em>APC</em>). (See <a href=\"topic.htm?path=gardner-syndrome\" class=\"medical medical_review\">&quot;Gardner syndrome&quot;</a>.)</p><p>The most characteristic skin feature is multiple epidermoid cysts. Other findings include desmoid tumors, lipomas, osteomas (especially of the mandible), supernumerary teeth, gastric polyps, and juvenile nasopharyngeal angiofibromas. Congenital hypertrophy of the retinal pigmented epithelium is a reliable and early marker of the disease when it is present. Prophylactic colectomy is recommended because of the nearly universal development of colorectal cancer in affected patients.</p><p>In addition to colorectal adenocarcinoma, patients with FAP are at risk for several extracolonic malignancies, including:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Duodenal ampullary carcinoma</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Follicular or papillary thyroid cancer</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Childhood hepatoblastoma</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gastric carcinoma</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Central nervous system (CNS) tumors (mostly medulloblastomas)</p><p/><p class=\"headingAnchor\" id=\"H523750957\"><span class=\"h2\">Peutz-Jeghers syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>PJS is a rare, autosomal dominant condition characterized by distinctive mucocutaneous pigmentations and multiple hamartomatous polyps in the gastrointestinal tract [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/5\" class=\"abstract_t\">5</a>]. Most cases are associated with mutations in the tumor suppressor gene <em>STK11</em> <span class=\"nowrap\">(serine/threonine</span> kinase <span class=\"nowrap\">11)/LKB1</span> [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/6\" class=\"abstract_t\">6</a>]. (See <a href=\"topic.htm?path=peutz-jeghers-syndrome-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Peutz-Jeghers syndrome: Epidemiology, clinical manifestations, and diagnosis&quot;</a>.)</p><p>The characteristic mucocutaneous pigmentations (lentigines) of PJS are present in more than 95 percent of patients and are caused by pigment-laden macrophages in the dermis. They are typically flat, blue-gray to brown spots 1 to 5 mm in size that look like freckles. However, the onset and location of PJS spots are different from those of freckles.</p><p>Lentigines occur most commonly on the lips and perioral region (94 percent), hands (74 percent), buccal mucosa (66 percent), and feet (62 percent) (<a href=\"image.htm?imageKey=GAST%2F80815\" class=\"graphic graphic_picture graphicRef80815 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/7\" class=\"abstract_t\">7</a>]. They also occur on the nose, perianal area, and genitals and are rarely found in the intestines. They usually occur during the first one to two years of life, increase in size and number over the ensuing years, and finally fade after puberty, with the exception of those on the buccal mucosa.</p><p>Gastrointestinal hamartomatous polyps are present in most patients with PJS, and patients may develop gastrointestinal malignancy. The risk of non-gastrointestinal cancers, including adenocarcinomas of the breast, cervix, pancreas, uterus, and ovaries, is also increased.</p><p class=\"headingAnchor\" id=\"H523750964\"><span class=\"h2\">Xeroderma pigmentosum</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>XP is a rare autosomal recessive disease that occurs in the United States at a frequency of approximately 1:250,000. Mutations have been identified as causative in genes that are involved in nucleotide excision repair of carcinogen adducts after ultraviolet irradiation. (See <a href=\"topic.htm?path=epidemiology-and-risk-factors-for-cutaneous-squamous-cell-carcinoma#H16\" class=\"medical medical_review\">&quot;Epidemiology and risk factors for cutaneous squamous cell carcinoma&quot;, section on 'Xeroderma pigmentosum'</a>.)</p><p>Homozygotes have severe sun sensitivity that leads to development of basal and squamous cell carcinomas and melanomas beginning in early childhood. The incidence of these malignancies for individuals younger than the age of 20 years is approximately 2000 times that seen in the general population. Other ocular abnormalities that may be seen include keratitis, opacification of the cornea, iritis with synechia formation, and melanoma of the choroid.</p><p>Approximately 20 percent of patients with XP have neurologic abnormalities of varying severity caused by primary neuronal degeneration. (See <a href=\"topic.htm?path=neuropathies-associated-with-hereditary-disorders#H25\" class=\"medical medical_review\">&quot;Neuropathies associated with hereditary disorders&quot;, section on 'Xeroderma pigmentosum'</a>.)</p><p class=\"headingAnchor\" id=\"H523750971\"><span class=\"h2\">Epidermolysis bullosa</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with particular subtypes of epidermolysis bullosa are at increased risk for cutaneous malignancy. (See <a href=\"topic.htm?path=epidemiology-pathogenesis-classification-and-clinical-features-of-epidermolysis-bullosa#H61550613\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, classification, and clinical features of epidermolysis bullosa&quot;, section on 'Skin cancer'</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">DISORDERS OF KERATINIZATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Keratins are intermediate filament proteins that form the cytoskeleton in all epithelial cells, including the stratified epithelium of the epidermis [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/8\" class=\"abstract_t\">8</a>]. Keratins represent the major proteins produced by the keratinocyte, which is the primary cell type of the epidermis. The maturation of basal epidermal cells to the flattened cells that constitute the superficial stratum corneum is known as keratinization [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/9\" class=\"abstract_t\">9</a>].</p><p>Approximately 50 genes that encode keratins have been identified in humans. The phenotype resulting from a particular mutation depends upon the tissue-specific expression pattern of that keratin.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Ichthyoses</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The ichthyoses are a diverse group of hereditary skin disorders characterized by the accumulation of &quot;fish-like&quot; scales resulting from abnormal epidermal cell kinetics or differentiation (<a href=\"image.htm?imageKey=PEDS%2F71157\" class=\"graphic graphic_table graphicRef71157 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/10\" class=\"abstract_t\">10</a>]. The severity of the individual disorders ranges from asymptomatic to life threatening.</p><p>The cornerstone of therapy for all types is aggressive hydration of the skin with emollients. When tolerated, keratolytics also may be used. Severe or extensive involvement may require systemic retinoids.</p><p>Referral to a dermatologist is indicated when basic treatment measures such as emollients are not working, when there are complications related to the skin condition, or if the diagnosis is not clear. Biopsy is useful for certain types of ichthyoses or disorders of cornification.</p><p>The major types of inherited ichthyoses are reviewed separately. Information for patients and families is available on the website of the <a href=\"http://firstskinfoundation.org/&amp;token=kwrI4rUNBiA5ezozlcrTeDZN8skg8J5yffE3vLmfhGp54OxCjqTEgGfBzgW1WPTC&amp;TOPIC_ID=3004\" target=\"_blank\" class=\"external\">Foundation for Ichthyosis and Related Skin Types</a>.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=overview-and-classification-of-the-inherited-ichthyoses\" class=\"medical medical_review\">&quot;Overview and classification of the inherited ichthyoses&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=recessive-x-linked-ichthyosis\" class=\"medical medical_review\">&quot;Recessive X-linked ichthyosis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=keratinopathic-ichthyoses\" class=\"medical medical_review\">&quot;Keratinopathic ichthyoses&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=netherton-syndrome\" class=\"medical medical_review\">&quot;Netherton syndrome&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=sjogren-larsson-syndrome\" class=\"medical medical_review\">&quot;Sj&ouml;gren-Larsson syndrome&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Palmoplantar keratodermas</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>These disorders share the common feature of palmar and plantar hyperkeratosis that manifests as thickening and scaling of the palms and soles. The general underlying defect in the majority of the palmoplantar keratodermas is overproduction of a normal or an abnormal keratin in the palms and soles. The majority of cases are mild to moderate, without systemic problems and with autosomal dominant inheritance.</p><p>The keratodermas differ in their mode of inheritance, severity, and extent of involvement and associated features [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/11,12\" class=\"abstract_t\">11,12</a>]. This is illustrated by the following examples of these disorders:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Howel-Evans syndrome is a rare, autosomal dominant diffuse form with onset between 5 and 15 years of age [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/13\" class=\"abstract_t\">13</a>]. It has been associated with the early development of esophageal cancer.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vohwinkel syndrome is a rare, autosomal dominant disorder in which patients may have autoamputation of the digits (pseudo-ainhum) and high-frequency hearing loss.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Papillon-Lef&egrave;vre syndrome is an autosomal recessive condition that presents in the first six months of life. Patients often have severe periodontitis, leading to early dental loss.</p><p/><p>Dermatologic management of these disorders includes regular application of emollients and keratolytic agents and physical removal of excess scale. Oral retinoids also have been beneficial in some cases. Secondary bacterial, viral, or fungal infections are a frequent complicating feature, necessitating appropriate treatment with antibiotics.</p><p class=\"headingAnchor\" id=\"H3247114\"><span class=\"h2\">Pachyonychia congenita</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pachyonychia congenita (PC) is an autosomal dominant disorder caused by mutations in the genes that encode keratins (<em>KRT6A</em>, <em>KRT6B</em>, <em>KRT16</em>, and <em>KRT17</em>), the type I and II intermediate filament proteins that form a cytoskeletal network in all epithelial cells [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/14\" class=\"abstract_t\">14</a>]. In PC, there are focal areas of hyperkeratosis on the soles plus hyperkeratosis of a variety of other tissues where these keratins are expressed, including the nails, oral mucosa, and other sites.</p><p>Affected patients present within the first year of life with thickened, discolored nails of the fingers and toes (<a href=\"image.htm?imageKey=DERM%2F52261\" class=\"graphic graphic_picture graphicRef52261 \">picture 3</a>). These changes are present at birth in approximately 50 percent of the affected children [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/15\" class=\"abstract_t\">15</a>]. Palmar and plantar hyperkeratoses and hyperhidrosis, follicular keratoses of the knees and elbows, and oral leukoplakia may develop within the first decade of life. Thickened nails and plantar hyperkeratoses may be extremely painful [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/16\" class=\"abstract_t\">16</a>]. Paronychia is a common complication. (See <a href=\"topic.htm?path=paronychia#H1\" class=\"medical medical_review\">&quot;Paronychia&quot;, section on 'Introduction'</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Darier disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Darier disease, also known as Darier-White disease or keratosis follicularis (MIM #124200), is an autosomal dominant disorder caused by mutations in the gene encoding the <span class=\"nowrap\">sarco/endoplasmic</span> reticulum Ca(+2)-ATPase [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/17\" class=\"abstract_t\">17</a>]. This results in loss of adhesion between epidermal cells and abnormal keratinization. The disorder is a relatively common genodermatosis with a frequency of up to 1 in 36,000 individuals [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/18\" class=\"abstract_t\">18</a>].</p><p>The disorder typically presents in the second decade of life with hyperkeratotic, yellow-brown, greasy-appearing papules that coalesce into verrucous-like plaques (<a href=\"image.htm?imageKey=DERM%2F56168%7EDERM%2F70000\" class=\"graphic graphic_picture graphicRef56168 graphicRef70000 \">picture 4A-B</a>) [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/19,20\" class=\"abstract_t\">19,20</a>]. The lesions are often pruritic and frequently become purulent and malodorous, especially if infected. Typical sites of involvement are in a seborrheic distribution: trunk, face, scalp, and groin. Nails may demonstrate <span class=\"nowrap\">red/white</span> vertical stripes, subungual hyperkeratosis, and notching of the distal nail margins (<a href=\"image.htm?imageKey=DERM%2F81865\" class=\"graphic graphic_picture graphicRef81865 \">picture 5</a>). Palmar keratosis and pits often are present.</p><p>The course of the illness is chronic and persistent, with characteristic worsening in summer months. Darier disease is discussed in detail separately. (See <a href=\"topic.htm?path=darier-disease\" class=\"medical medical_review\">&quot;Darier disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">GENETIC BLISTERING DISORDERS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>These disorders result from abnormalities in the cohesion of the layers of the epidermis. They result in separation of the layers in response to minimal injury.</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Epidermolysis bullosa</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Epidermolysis bullosa (EB) constitutes a clinically and genetically heterogeneous group of rare inherited disorders characterized by marked skin and mucosal fragility caused by mutations in skin structural proteins. There are four major types of EB, based upon the ultrastructural level of tissue cleavage in the skin: EB simplex, junctional EB, dystrophic EB, and Kindler syndrome (<a href=\"image.htm?imageKey=PEDS%2F76897\" class=\"graphic graphic_table graphicRef76897 \">table 3</a>) [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/21,22\" class=\"abstract_t\">21,22</a>]. Many subtypes have been identified based upon clinical, pathophysiologic, and molecular criteria (<a href=\"image.htm?imageKey=DERM%2F77709%7EDERM%2F67202%7EDERM%2F55262%7EDERM%2F81536\" class=\"graphic graphic_table graphicRef77709 graphicRef67202 graphicRef55262 graphicRef81536 \">table 4A-D</a>).</p><p>The clinical features, diagnosis, and management of EB are discussed in detail separately. (See <a href=\"topic.htm?path=epidemiology-pathogenesis-classification-and-clinical-features-of-epidermolysis-bullosa\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, classification, and clinical features of epidermolysis bullosa&quot;</a> and <a href=\"topic.htm?path=diagnosis-of-epidermolysis-bullosa\" class=\"medical medical_review\">&quot;Diagnosis of epidermolysis bullosa&quot;</a> and <a href=\"topic.htm?path=overview-of-the-management-of-epidermolysis-bullosa\" class=\"medical medical_review\">&quot;Overview of the management of epidermolysis bullosa&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h1\">PIGMENTATION DISORDERS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Melanin, a black or brown pigment formed from tyrosine, is responsible for the color of skin and hair [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/23\" class=\"abstract_t\">23</a>]. Melanin is synthesized in melanocytes, which are specialized, dendritic secretory cells derived from the neural crest. These cells migrate to the basal layer of the epidermis during embryogenesis. The presence of melanin in the epidermis helps provide protection from ultraviolet radiation. </p><p>Disorders include decreased and excessive pigmentation. Diagnosis is based on the clinical features in most cases, although some may be clarified with molecular testing.</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Oculocutaneous albinism</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Oculocutaneous albinism (OCA) is a group of rare genetic disorders of melanin biosynthesis inherited in an autosomal recessive pattern [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/24,25\" class=\"abstract_t\">24,25</a>]. There are seven types of OCA caused by mutations in different genes (<a href=\"image.htm?imageKey=DERM%2F115427\" class=\"graphic graphic_table graphicRef115427 \">table 5</a>). Although all types share absent or reduced pigmentation of the hair, skin, and eyes, the clinical phenotypes vary along a broad spectrum of disease severity.</p><p>The pathogenesis, clinical manifestations, diagnosis, and management of OCA are discussed in detail separately. (See <a href=\"topic.htm?path=oculocutaneous-albinism\" class=\"medical medical_review\">&quot;Oculocutaneous albinism&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Ocular albinism</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ocular albinism is albinism in which the hypopigmentation is primarily limited to the eyes [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/26,27\" class=\"abstract_t\">26,27</a>]. It is less common than oculocutaneous albinism.</p><p>Ocular albinism type 1 (OA1, MIM #300500), also known as Nettleship-Falls ocular albinism, is the most common form of ocular albinism and has X-linked recessive inheritance. It has an estimated prevalence of 1 in 50,000 to 150,000 live births [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/28,29\" class=\"abstract_t\">28,29</a>].</p><p>The clinical manifestations of OA1 are variable. In affected males, clinical features may include mild cutaneous hypopigmentation, hypopigmentation of the iris and retina, foveal hypoplasia, prominent choroidal vessels, nystagmus, strabismus, head nodding, photophobia, impaired vision, and abnormal crossing of the optic fibers resulting in deficient stereoscopic vision [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/27,30,31\" class=\"abstract_t\">27,30,31</a>]. Female carriers may have a patchy distribution of retinal pigmentation resulting from X-inactivation [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/27,32\" class=\"abstract_t\">27,32</a>].</p><p>OA1 is diagnosed by careful analysis of the family pedigree for X-linked inheritance <span class=\"nowrap\">and/or</span> molecular analysis of the OA1 gene [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/32\" class=\"abstract_t\">32</a>]. The severity of OA1 appears to be related to ethnic background, with individuals from lightly pigmented racial groups more severely affected than those from darkly pigmented groups [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/33-35\" class=\"abstract_t\">33-35</a>]. Life expectancy is normal [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/26\" class=\"abstract_t\">26</a>].</p><p>OA1 has been associated with late-onset sensorineural deafness. This form (OASD, MIM 300650) is probably a contiguous gene defect that includes the OA1 gene [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/36,37\" class=\"abstract_t\">36,37</a>]. Another form of ocular albinism with sensorineural deafness has been linked to chromosome 11 and has autosomal recessive inheritance; this form is also known as Waardenburg syndrome type II (MIM 103470) [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/38\" class=\"abstract_t\">38</a>]. (See <a href=\"#H24\" class=\"local\">'Waardenburg syndrome'</a> below.)</p><p>Ocular albinism type II (OA2, MIM #300600), also known as Forsius-Eriksson type ocular albinism and Aland Island eye disease, is a rare, X-linked disorder with clinical manifestations that include nystagmus, myopia, astigmatism, foveal hypoplasia, reduced visual acuity, pigmentary changes in the retina, and changes in color vision; the optic nerves are normal [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/26\" class=\"abstract_t\">26</a>].</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h2\">Piebaldism</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Piebaldism (piebald trait) is a rare, autosomal dominant disorder in which cell proliferation and migration of neural-crest-derived melanoblasts are defective. This leads to an abnormal distribution of melanocytes during embryogenesis and results in patchy areas of depigmentation [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/39\" class=\"abstract_t\">39</a>]. The disorder is caused by mutations in the cell-surface receptor tyrosine kinase gene (<em>KIT</em>) [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/40\" class=\"abstract_t\">40</a>].</p><p>Affected patients have patches of depigmented skin, with hyperpigmented borders occurring principally on the midforehead, neck, anterior trunk, and mid-extremities (<a href=\"image.htm?imageKey=DERM%2F58857%7EDERM%2F52591%7EDERM%2F71514\" class=\"graphic graphic_picture graphicRef58857 graphicRef52591 graphicRef71514 \">picture 6A-C</a>). Normal pigmentation occurs on the hands, feet, back, shoulders, and hips. A white forelock is a common finding. The depigmentation is stable and permanent. Patients with piebaldism are generally otherwise healthy and have normal life spans.</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h2\">Waardenburg syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Waardenburg syndrome is another autosomal dominant inherited pigmentary disorder in which abnormal distribution of melanocytes during embryogenesis results in patchy areas of depigmentation [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/39,41,42\" class=\"abstract_t\">39,41,42</a>]. Several forms of Waardenburg syndrome are described. All have the clinical features of type 1, which is characterized by a piebald-like distribution of patchy depigmentation of the hair and skin. Other distinctive noncutaneous features include pigmentary abnormalities of the iris (heterochromia irides) and a broad nasal root, secondary to lateral displacement of the inner canthi of the eyes (<a href=\"image.htm?imageKey=PEDS%2F56776\" class=\"graphic graphic_picture graphicRef56776 \">picture 7</a>). Congenital deafness occurs in one in five patients with Waardenburg syndrome, and, conversely, an estimated 2 to 7 percent of cases of congenital deafness result from the disorder [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/43,44\" class=\"abstract_t\">43,44</a>]. Occasional findings in Waardenburg syndrome type 1 include cleft lip and palate and neural tube defects (eg, spina bifida, myelomeningocele) [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/45\" class=\"abstract_t\">45</a>].</p><p>Waardenburg syndrome type 1 (MIM #193500) and type 3 (MIM #148820) are caused by mutations in the gene for one of three transcription factors <em>PAX3</em>, whereas type 2 (MIM #193510) is caused by mutations in the transcription factor <em>MITF</em> [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/46,47\" class=\"abstract_t\">46,47</a>]. Waardenburg syndrome type 4 (MIM #277580) also has features of Hirschsprung disease. This type is a result of biallelic mutation in the genes for the endothelin-B receptor (<em>EDNRB</em>) or its ligand endothelin-B (<em>EDN3</em>) [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/48,49\" class=\"abstract_t\">48,49</a>] or heterozygous mutation in the <em>SOX10</em> gene [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/50\" class=\"abstract_t\">50</a>]. (See <a href=\"topic.htm?path=congenital-aganglionic-megacolon-hirschsprung-disease\" class=\"medical medical_review\">&quot;Congenital aganglionic megacolon (Hirschsprung disease)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H29839266\"><span class=\"h1\">NEUROCUTANEOUS SYNDROMES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neurocutaneous genetic disorders, also called phakomatoses, may present with a variety of neurologic and cutaneous findings. Examples include the neurofibromatoses and tuberous sclerosis complex.</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h2\">Neurofibromatosis type 1</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neurofibromatosis type 1 (NF1), also known as von Recklinghausen's disease, is an autosomal dominant neurocutaneous disorder with nervous system, skeletal, and dermatologic manifestations [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/51\" class=\"abstract_t\">51</a>]. It is caused by mutations in the <em>NF1</em> gene, encoding the protein neurofibromin. (See <a href=\"topic.htm?path=neurofibromatosis-type-1-nf1-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis&quot;</a>.)</p><p>The characteristic skin findings that contribute to establishing the diagnosis are:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Six or more cafe-au-lait macules of greatest diameter &gt;5 mm in prepubertal and &gt;15 mm in postpubertal individuals (<a href=\"image.htm?imageKey=PEDS%2F69606\" class=\"graphic graphic_picture graphicRef69606 \">picture 8A</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Two or more neurofibromas of any type or one plexiform neurofibroma (<a href=\"image.htm?imageKey=DERM%2F82613\" class=\"graphic graphic_picture graphicRef82613 \">picture 8B</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Freckling in the axillary or inguinal regions (Crowe sign) (<a href=\"image.htm?imageKey=DERM%2F67532\" class=\"graphic graphic_picture graphicRef67532 \">picture 8C</a>)</p><p/><p class=\"headingAnchor\" id=\"H27\"><span class=\"h2\">Neurofibromatosis type 2</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neurofibromatosis type 2 (NF2) is the central form of neurofibromatosis and is characterized by bilateral vestibular schwannomas (acoustic neuromas), meningiomas of the brain, and <span class=\"nowrap\">schwannomas/neurilemmomas</span> of the dorsal roots of the spinal cord. The disorder typically presents in the teens or soon after puberty with unilateral hearing loss. In contrast to NF1, cafe-au-lait spots in NF2 are typically few, large, and relatively light in color [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/52\" class=\"abstract_t\">52</a>]. NF2 is caused by mutations in the gene encoding the intracellular membrane-associated protein neurofibromin-2 (NF-2), a tumor suppressor, which is also known as merlin [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/53\" class=\"abstract_t\">53</a>]. (See <a href=\"topic.htm?path=neurofibromatosis-type-2\" class=\"medical medical_review\">&quot;Neurofibromatosis type 2&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h2\">Tuberous sclerosis complex</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous disorder whose skin findings are often the first clues to its diagnosis [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/54,55\" class=\"abstract_t\">54,55</a>]. TSC is caused by mutations in one of two genes: <em>TSC1</em>, which encodes hamartin, and <em>TSC2</em>, which encodes tuberin. (See <a href=\"topic.htm?path=tuberous-sclerosis-complex-genetics-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Tuberous sclerosis complex: Genetics, clinical features, and diagnosis&quot;</a>.)</p><p>It is estimated that more than 95 percent of patients with TSC have one of the characteristic skin lesions [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/55\" class=\"abstract_t\">55</a>]. The most common lesions are:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypopigmented macules, also known as ash-leaf spots, which are usually elliptical in shape (<a href=\"image.htm?imageKey=PEDS%2F61601\" class=\"graphic graphic_picture graphicRef61601 \">picture 9A</a>). These are often present at birth, although a Wood's lamp examination may be required to visualize them.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Angiofibromas, previously called adenoma sebaceum, which typically involve the malar regions of the face (<a href=\"image.htm?imageKey=PEDS%2F54868\" class=\"graphic graphic_picture graphicRef54868 \">picture 9B</a>) and usually become apparent by late childhood or early adolescence.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Shagreen patches (connective tissue nevi), seen most commonly over the lower trunk.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A distinctive brown, fibrous plaque on the forehead, which may be the first and most readily recognized feature of TSC to appear on physical examination of affected neonates and infants (<a href=\"image.htm?imageKey=PEDS%2F78688\" class=\"graphic graphic_picture graphicRef78688 \">picture 10</a>) [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/55\" class=\"abstract_t\">55</a>].</p><p/><p class=\"headingAnchor\" id=\"H30\"><span class=\"h2\">Ataxia-telangiectasia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ataxia-telangiectasia (AT, also known as Louis-Bar syndrome) is an autosomal recessive disorder caused by mutations in the gene designated <em>ATM</em> (<strong>AT</strong>&nbsp;<strong>m</strong>utated). The <em>ATM</em> gene, which is expressed in all tissues in the body, is involved in the detection of DNA damage and plays an important role in cell cycle progression. The pathogenesis of AT is thought to be a defect in DNA repair resulting in increased sensitivity to ionizing radiation, immunodeficiency, and progressive cerebellar Purkinje cell death. </p><p>Patients with AT suffer from progressive cerebellar ataxia and other neurologic abnormalities, oculocutaneous telangiectasias, and immune deficiency. Associated features are an increased incidence of malignancy, radiation sensitivity, and diabetes mellitus caused by insulin resistance. (See <a href=\"topic.htm?path=ataxia-telangiectasia\" class=\"medical medical_review\">&quot;Ataxia-telangiectasia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H29839329\"><span class=\"h1\">VASCULAR DISORDERS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Inherited syndromes associated with cutaneous vascular abnormalities include ataxia-telangiectasia (AT) and hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome. These disorders are discussed separately. (See <a href=\"topic.htm?path=ataxia-telangiectasia\" class=\"medical medical_review\">&quot;Ataxia-telangiectasia&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-syndrome\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H32\"><span class=\"h1\">DISORDERS OF CONNECTIVE TISSUE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Abnormalities of connective tissue are frequently expressed in the skin. Thus, multisystem inherited connective tissue disorders such as Ehlers-Danlos syndrome, Marfan syndrome, and osteogenesis imperfecta can be classified as genodermatoses. Pseudoxanthoma elasticum (PXE) and focal dermal hypoplasia are less common connective tissue disorders with prominent skin abnormalities.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-ehlers-danlos-syndromes\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Ehlers-Danlos syndromes&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=overview-of-the-management-of-ehlers-danlos-syndromes\" class=\"medical medical_review\">&quot;Overview of the management of Ehlers-Danlos syndromes&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=genetics-clinical-features-and-diagnosis-of-marfan-syndrome-and-related-disorders\" class=\"medical medical_review\">&quot;Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=management-of-marfan-syndrome-and-related-disorders\" class=\"medical medical_review\">&quot;Management of Marfan syndrome and related disorders&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=osteogenesis-imperfecta-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Osteogenesis imperfecta: Clinical features and diagnosis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=osteogenesis-imperfecta-management-and-prognosis\" class=\"medical medical_review\">&quot;Osteogenesis imperfecta: Management and prognosis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H33\"><span class=\"h2\">Pseudoxanthoma elasticum</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>PXE (also called Gr&ouml;nblad-Strandberg syndrome, MIM #264800 and #177850) is a genetic disorder of abnormal elastic tissue (fragmentation of elastic fibers) and calcification. Inherited forms are autosomal recessive, but sporadic forms have been observed [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/56\" class=\"abstract_t\">56</a>]. The underlying defect is a mutation in the <em>ABCC6</em> gene on chromosome 16 that encodes an ATP-binding cassette transporter [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/57-59\" class=\"abstract_t\">57-59</a>].</p><p>The onset of the disorder varies from childhood to early adulthood, although the characteristic skin findings may be subtle in children. The primary organ systems involved include the skin, eyes, and cardiovascular systems; gastrointestinal bleeding also can occur [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/60-62\" class=\"abstract_t\">60-62</a>].</p><p>Progressive skin lesions develop in 80 percent of individuals before age 20 years. The characteristic skin findings are 2 to 5 mm yellow to orange papules, which may coalesce into irregularly shaped plaques surrounded by normal skin. Because such lesions have a pebbly appearance and are yellow, they are named pseudoxanthomas. The texture of the skin has been likened to plucked-chicken skin. Lesions occur most commonly in flexural areas such as the neck and axillary folds, periumbilical region, and on the inner lower lip (<a href=\"image.htm?imageKey=DERM%2F80952%7EDERM%2F59135%7EDERM%2F70421%7EDERM%2F76225\" class=\"graphic graphic_picture graphicRef80952 graphicRef59135 graphicRef70421 graphicRef76225 \">picture 11A-D</a>). The involved skin may eventually become lax and redundant.</p><p>The primary ocular finding is that of angioid streaks, representing tears in Bruch's membrane, but this finding is seen in other disorders as well (<a href=\"image.htm?imageKey=DERM%2F77863\" class=\"graphic graphic_picture graphicRef77863 \">picture 11E</a>). Macular degeneration and retinal deformities contribute to loss of central vision. Severe vision loss occurs in 3 to 8 percent of patients.</p><p>Common cardiovascular manifestations include accelerated atherosclerosis, which is thought to result from calcification of the internal elastic laminae. These changes can result in myocardial infarction, cerebrovascular disease, and renovascular hypertension at a young age and result in a shortened life expectancy.</p><p>The diagnosis of PXE is based upon the clinical appearance and findings on histologic examination of lesional skin. Treatment consists of close ophthalmologic management, monitoring and treatment of any cardiovascular symptoms, and dietary consultation. Because of the risk of ocular disease, patients should be educated to avoid contact sports and straining (eg, weight lifting) [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/62\" class=\"abstract_t\">62</a>]. They should be referred for genetic counseling.</p><p class=\"headingAnchor\" id=\"H29839606\"><span class=\"h1\">X-LINKED DOMINANT DISORDERS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Incontinentia pigmenti (IP), focal dermal hypoplasia, congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD syndrome, MIM #308050), and chondrodysplasia punctata (Conradi-H&uuml;nermann-Happle syndrome, MIM #302960) [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/63,64\" class=\"abstract_t\">63,64</a>] are examples of X-linked dominant disorders with cutaneous manifestations. IP and focal dermal hypoplasia are reviewed below.</p><p class=\"headingAnchor\" id=\"H29839499\"><span class=\"h2\">Incontinentia pigmenti</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Incontinentia pigmenti (IP), also known as Bloch-Sulzberger syndrome (MIM #308300), is a rare genodermatosis that presents in the neonatal period [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/65,66\" class=\"abstract_t\">65,66</a>]. It is an X-linked dominant disorder caused by mutations in the <em><span class=\"nowrap\">IKBKG/NEMO</span> </em>(inhibitor of kappa polypeptide gene enhancer in B cells, kinase <span class=\"nowrap\">gamma/nuclear</span> factor-kappa B essential modulator) gene [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/67\" class=\"abstract_t\">67</a>]. The gene encodes a regulatory protein involved in the activation of genes involved in cell survival, inflammation, and immunity.</p><p>The disease typically is lethal in males prenatally. Thus, virtually all affected infants are female. Survival in male patients may be related to genetic heterogeneity or postzygotic mosaicism. </p><p>The pathogenesis, clinical features, diagnosis, and management of IP are discussed separately. (See <a href=\"topic.htm?path=incontinentia-pigmenti\" class=\"medical medical_review\">&quot;Incontinentia pigmenti&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H34\"><span class=\"h2\">Focal dermal hypoplasia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Focal dermal hypoplasia, also known as Goltz syndrome, is a rare but serious multisystem connective tissue genodermatosis [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/68\" class=\"abstract_t\">68</a>]. The disorder is X-linked dominant; 90 percent of those affected are female. The mutation is often lethal in males. All cases in surviving males have been due to de novo mutations [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/69\" class=\"abstract_t\">69</a>]. This suggests possible X-chromosome inactivation and somatic mosaicism. Focal dermal hypoplasia has been associated with heterozygous and mosaic mutations in <em>PORCN</em>, a member of the porcupine gene family, which encodes endoplasmic reticulum proteins that are involved in Wnt protein secretion [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/70,71\" class=\"abstract_t\">70,71</a>].</p><p>The dermatologic features include linear or serpiginous streaks of dermal hypoplasia associated with pigmentary changes, telangiectasias, and yellowish-brown nodules of fat herniation (<a href=\"image.htm?imageKey=DERM%2F55714\" class=\"graphic graphic_picture graphicRef55714 \">picture 12</a>). The lesions often follow the lines of Blaschko. Papillomas of the lips, perineum, axilla, and periumbilical area also may be seen.</p><p>Noncutaneous manifestations of the disorder include asymmetric skeletal development. Severe skeletal deformities, such as &quot;lobster-claw&quot; hands, often occur. Ocular, dental, and craniofacial abnormalities also may be seen. Approximately 15 percent of affected individuals have mild intellectual disability (mental retardation).</p><p class=\"headingAnchor\" id=\"H35\"><span class=\"h1\">ECTODERMAL DYSPLASIAS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The ectodermal dysplasia are a large group of inherited disorders that manifest as developmental abnormalities of the skin and its appendages, such as hair, nails, teeth, and sweat glands, and other ectodermal structures. Examples include anhidrotic ectodermal dysplasia, hidrotic ectodermal dysplasia, and ankyloblepharon-ectodermal defects-cleft <span class=\"nowrap\">lip/palate</span>.</p><p class=\"headingAnchor\" id=\"H36\"><span class=\"h2\">Anhidrotic ectodermal dysplasia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Anhidrotic ectodermal dysplasia, also known as hypohidrotic ectodermal dysplasia (EDA or HED, MIM #305100), is an X-linked disorder thought to result from an embryologic defect in ectodermal development. The disorder has been associated with mutations in at least three genes that also are involved in the activation of the transcription factor NF-kappa B, which regulates the expression of genes that control immune and stress responses, inflammatory reaction, cell adhesion, and protection against apoptosis [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/72,73\" class=\"abstract_t\">72,73</a>]. These genes are ectodysplasin (<em>EDA1</em>); EDA-receptor (<em>EDAR</em>), which can be inherited in an autosomal dominant or autosomal recessive fashion with indistinguishable clinical features [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/74\" class=\"abstract_t\">74</a>]; and EDAR-associated death domain (<em>EDARADD</em>), which is an allelic variant.</p><p>Anhidrotic ectodermal dysplasia is characterized by partial or complete absence of the eccrine sweat glands, resulting in reduced or absent sweating. The disorder typically presents with life-threatening hyperpyrexia and heat intolerance. Patients also have characteristic facies with prominent frontal bossing, a saddle nose, sunken cheeks, protruding lips, and sparse hair (<a href=\"image.htm?imageKey=DERM%2F80851\" class=\"graphic graphic_picture graphicRef80851 \">picture 13A</a>). Hypodontia, conical &quot;peg teeth,&quot; or anodontia also are frequently seen (<a href=\"image.htm?imageKey=DERM%2F66563\" class=\"graphic graphic_picture graphicRef66563 \">picture 13B</a>). The nails are generally thin and ridged. Female carriers of the disease may have minor abnormalities. Growth abnormalities, particularly decreased weight, are common [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/75\" class=\"abstract_t\">75</a>].</p><p>The diagnosis is usually based upon clinical features, although molecular testing is available. Skin biopsy, performed in the past to quantify sweat glands, is not necessary.</p><p>Treatment is difficult and is directed at maintaining temperature stability [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/76\" class=\"abstract_t\">76</a>]. Physical exertion and warm climates should be avoided. Cooling vests and water spray misters may be helpful in warm environments.</p><p class=\"headingAnchor\" id=\"H37\"><span class=\"h2\">Hypohidrotic ectodermal dysplasia with immunodeficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypohidrotic ectodermal dysplasia with immunodeficiency (HED-ID, MIM #300291) is caused by mutations in the gene known as NEMO (NF-kappa essential modulator, also known as IKK-gamma). It is typically an X-linked recessive trait but also can be inherited in an autosomal dominant or autosomal recessive fashion. This disorder is reviewed separately. (See <a href=\"topic.htm?path=combined-immunodeficiencies#H18\" class=\"medical medical_review\">&quot;Combined immunodeficiencies&quot;, section on 'Defects of NF-kappa-B regulation'</a>.)</p><p class=\"headingAnchor\" id=\"H38\"><span class=\"h2\">Hidrotic ectodermal dysplasia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hidrotic ectodermal dysplasia is an autosomal dominant condition that is more common and generally less severe than its anhidrotic counterpart. It is caused by mutations in the <em>GJB6</em> gene, which encodes connexin 30, a component of the gap junction complex [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/77,78\" class=\"abstract_t\">77,78</a>]. Hidrotic ectodermal dysplasia is most common in the French-Canadian and French populations.</p><p>The disorder is characterized by slowly growing dystrophic nails, patchy alopecia, and hyperkeratotic palms and soles [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/79\" class=\"abstract_t\">79</a>]. Eccrine sweat glands are present and active. Facial features are normal. Height and weight may be diminished compared with the reference population [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/75\" class=\"abstract_t\">75</a>].</p><p class=\"headingAnchor\" id=\"H39\"><span class=\"h2\">Ankyloblepharon-ectodermal defects-cleft lip/palate</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ankyloblepharon-ectodermal defects-cleft <span class=\"nowrap\">lip/palate</span> is an autosomal dominant disorder (AEC, MIM #106260). It is also known as Hay-Wells syndrome [<a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/80\" class=\"abstract_t\">80</a>]. It is caused by mutations in the sterile alpha motif (SAM) domain of the p63 gene, which is a tumor protein shown to have strong homology to the tumor suppressor p53, and produces six isoforms found in proliferating basal cells of epithelial tissue.</p><p>Clinically, infants present with erythroderma and erosions, especially of the scalp. Infants are particularly at risk for dehydration, electrolyte imbalances, and infections related to skin erosions. Another classic finding in the neonatal period is ankyloblepharon filiforme adnatum, which are fine interpalpebral strands of tissue that lyse spontaneously in most cases. The skin findings eventuate into chronic ichthyosiform scaling, sparse hair with scarring alopecia, nail dystrophy, and heat intolerance.</p><p>Treatment is focused on skin care. Trauma or debridement of wounds should be limited. Gentle wound care with bland emollients and silicone-based dressings is recommended. Topical corticosteroids may be helpful in suppressing itching and inflammation. Antimicrobials should be used as necessary for secondary infections.</p><p class=\"headingAnchor\" id=\"H5358994\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The genodermatoses are a heterogeneous group of rare inherited single-gene disorders with skin manifestations. Recognition is important for the initiation of appropriate dermatologic therapy and detection of other associated abnormalities, including malignancy. (See <a href=\"#H523750729\" class=\"local\">'Overview'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Genodermatoses associated with the development of cutaneous and noncutaneous malignancies include basal cell nevus syndrome (<a href=\"image.htm?imageKey=ONC%2F72687\" class=\"graphic graphic_picture graphicRef72687 \">picture 1</a>), Gardner syndrome, Peutz-Jeghers syndrome (PJS) (<a href=\"image.htm?imageKey=GAST%2F80815\" class=\"graphic graphic_picture graphicRef80815 \">picture 2</a>), and xeroderma pigmentosum (XP) (<a href=\"image.htm?imageKey=PEDS%2F72060\" class=\"graphic graphic_table graphicRef72060 \">table 1</a>). (See <a href=\"#H523750890\" class=\"local\">'Disorders with malignant potential'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Keratins form the cytoskeleton in epithelial cells. Disorders of keratinization include the ichthyosiform dermatoses (<a href=\"image.htm?imageKey=PEDS%2F71157\" class=\"graphic graphic_table graphicRef71157 \">table 2</a> and <a href=\"image.htm?imageKey=DERM%2F61258%7EPEDS%2F66723%7EPEDS%2F59842\" class=\"graphic graphic_picture graphicRef61258 graphicRef66723 graphicRef59842 \">picture 14A-C</a>), palmoplantar keratodermas (<a href=\"image.htm?imageKey=DERM%2F52261\" class=\"graphic graphic_picture graphicRef52261 \">picture 3</a>), pachyonychia congenita, and Darier disease (<a href=\"image.htm?imageKey=DERM%2F56168%7EDERM%2F70000\" class=\"graphic graphic_picture graphicRef56168 graphicRef70000 \">picture 4A-B</a>). (See <a href=\"#H2\" class=\"local\">'Disorders of keratinization'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abnormalities in the cohesion of the layers of the epidermis underlie the congenital blistering disorders (ie, the epidermolysis bullosa syndromes), in which blister formation occurs with little or no trauma (<a href=\"image.htm?imageKey=DERM%2F59364%7EDERM%2F73201\" class=\"graphic graphic_picture graphicRef59364 graphicRef73201 \">picture 15A-B</a>). (See <a href=\"#H13\" class=\"local\">'Epidermolysis bullosa'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Congenital defects in melanin synthesis lead to pigmentation disorders. These include oculocutaneous albinism, a group of autosomal recessive disorders resulting in hypopigmentation of the hair, skin, and eyes (<a href=\"image.htm?imageKey=DERM%2F70579\" class=\"graphic graphic_table graphicRef70579 \">table 6</a>); piebaldism; and Waardenburg syndrome (<a href=\"image.htm?imageKey=PEDS%2F56776\" class=\"graphic graphic_picture graphicRef56776 \">picture 7</a>). (See <a href=\"#H18\" class=\"local\">'Pigmentation disorders'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cutaneous findings are often a key to the diagnosis of the most common neurocutaneous syndromes: neurofibromatosis (<a href=\"image.htm?imageKey=PEDS%2F69606%7EDERM%2F82613%7EDERM%2F67532\" class=\"graphic graphic_picture graphicRef69606 graphicRef82613 graphicRef67532 \">picture 8A-C</a>), tuberous sclerosis complex (TSC) (<a href=\"image.htm?imageKey=PEDS%2F61601%7EPEDS%2F54868\" class=\"graphic graphic_picture graphicRef61601 graphicRef54868 \">picture 9A-B</a>), and ataxia-telangiectasia (AT). (See <a href=\"#H29839266\" class=\"local\">'Neurocutaneous syndromes'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Multisystem inherited connective tissue disorders include Ehlers-Danlos syndrome, Marfan syndrome, osteogenesis imperfecta, and pseudoxanthoma elasticum (<a href=\"image.htm?imageKey=DERM%2F80952%7EDERM%2F59135%7EDERM%2F77863\" class=\"graphic graphic_picture graphicRef80952 graphicRef59135 graphicRef77863 \">picture 11A-B, 11E</a>). (See <a href=\"#H32\" class=\"local\">'Disorders of connective tissue'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>X-linked disorders with cutaneous manifestations include incontinentia pigmenti (<a href=\"image.htm?imageKey=DERM%2F58769\" class=\"graphic graphic_picture graphicRef58769 \">picture 16</a>) and focal dermal hypoplasia (<a href=\"image.htm?imageKey=DERM%2F55714\" class=\"graphic graphic_picture graphicRef55714 \">picture 12</a>). (See <a href=\"#H29839606\" class=\"local\">'X-linked dominant disorders'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The ectodermal dysplasias are inherited diseases involving tissues of ectodermal origin. They include anhidrotic ectodermal dysplasia (<a href=\"image.htm?imageKey=DERM%2F80851%7EDERM%2F66563\" class=\"graphic graphic_picture graphicRef80851 graphicRef66563 \">picture 13A-B</a>), hypohidrotic ectodermal dysplasia, hidrotic ectodermal dysplasia, and ankyloblepharon-ectodermal defects-cleft <span class=\"nowrap\">lip/palate</span>. (See <a href=\"#H35\" class=\"local\">'Ectodermal dysplasias'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Spitz JL. Genodermatoses: A Full-Color Clinical Guide to Genetic Skin Disorders, Williams &amp; Wilkins, New York 1996.</li><li class=\"breakAll\">Sybert VP. Genetic Skin Disorders, Oxford University Press, New York 1997.</li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/3\" class=\"nounderline abstract_t\">Reyes MA, Eisen DB. Inherited syndromes. Dermatol Ther 2010; 23:606.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/4\" class=\"nounderline abstract_t\">Perniciaro C. Gardner's syndrome. Dermatol Clin 1995; 13:51.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/5\" class=\"nounderline abstract_t\">Griffith CD, Bisset WH. Peutz-Jeghers syndrome. Arch Dis Child 1980; 55:866.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/6\" class=\"nounderline abstract_t\">Scott RJ, Crooks R, Meldrum CJ, et al. Mutation analysis of the STK11/LKB1 gene and clinical characteristics of an Australian series of Peutz-Jeghers syndrome patients. Clin Genet 2002; 62:282.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/7\" class=\"nounderline abstract_t\">Utsunomiya J, Gocho H, Miyanaga T, et al. Peutz-Jeghers syndrome: its natural course and management. Johns Hopkins Med J 1975; 136:71.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/8\" class=\"nounderline abstract_t\">Porter RM, Lane EB. Phenotypes, genotypes and their contribution to understanding keratin function. Trends Genet 2003; 19:278.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/9\" class=\"nounderline abstract_t\">Roop D. Defects in the barrier. Science 1995; 267:474.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/10\" class=\"nounderline abstract_t\">Oji V, Tadini G, Akiyama M, et al. Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sor&egrave;ze 2009. J Am Acad Dermatol 2010; 63:607.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/11\" class=\"nounderline abstract_t\">Itin PH, Lautenschlager S. Palmoplantar keratoderma and associated syndromes. Semin Dermatol 1995; 14:152.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/12\" class=\"nounderline abstract_t\">Lucker GP, Van de Kerkhof PC, Steijlen PM. The hereditary palmoplantar keratoses: an updated review and classification. Br J Dermatol 1994; 131:1.</a></li><li class=\"breakAll\">Hereditary disorders of cornification. In: Hurwitz Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence, 3rd ed, Paller AS, Mancini AJ (Eds), W.B. Elsevier Saunders, Philadelphia 2006. p.107.</li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/14\" class=\"nounderline abstract_t\">Smith F. The molecular genetics of keratin disorders. Am J Clin Dermatol 2003; 4:347.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/15\" class=\"nounderline abstract_t\">Shah S, Boen M, Kenner-Bell B, et al. Pachyonychia congenita in pediatric patients: natural history, features, and impact. JAMA Dermatol 2014; 150:146.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/16\" class=\"nounderline abstract_t\">Eliason MJ, Leachman SA, Feng BJ, et al. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol 2012; 67:680.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/17\" class=\"nounderline abstract_t\">Sakuntabhai A, Ruiz-Perez V, Carter S, et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat Genet 1999; 21:271.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/18\" class=\"nounderline abstract_t\">Ringpfeil F, Raus A, DiGiovanna JJ, et al. Darier disease--novel mutations in ATP2A2 and genotype-phenotype correlation. Exp Dermatol 2001; 10:19.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/19\" class=\"nounderline abstract_t\">Burge S. Darier's disease--the clinical features and pathogenesis. Clin Exp Dermatol 1994; 19:193.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/20\" class=\"nounderline abstract_t\">Burge SM, Wilkinson JD. Darier-White disease: a review of the clinical features in 163 patients. J Am Acad Dermatol 1992; 27:40.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/21\" class=\"nounderline abstract_t\">Fine JD, Eady RA, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008; 58:931.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/22\" class=\"nounderline abstract_t\">Intong LR, Murrell DF. Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clin Dermatol 2012; 30:70.</a></li><li class=\"breakAll\">Disorders of pigmentation. In: Hurwitz Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence, 3rd ed, Paller AS, Mancini AJ (Eds), W.B. Elsevier Saunders, Philadelphia 2006. p.265.</li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/24\" class=\"nounderline abstract_t\">Summers CG. Albinism: classification, clinical characteristics, and recent findings. Optom Vis Sci 2009; 86:659.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/25\" class=\"nounderline abstract_t\">Gr&oslash;nskov K, Ek J, Brondum-Nielsen K. Oculocutaneous albinism. Orphanet J Rare Dis 2007; 2:43.</a></li><li class=\"breakAll\">King RA, Hearing VJ, Dreel DJ, Oetting WS. Albinism. In: Metabolic and Molecular Bases of Inherited Disease, 8th ed, Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw-Hill, New York 2001. p.5587.</li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/27\" class=\"nounderline abstract_t\">Spritz RA. Molecular genetics of oculocutaneous albinism. Hum Mol Genet 1994; 3 Spec No:1469.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/28\" class=\"nounderline abstract_t\">Rosenberg T, Schwartz M. X-linked ocular albinism: prevalence and mutations--a national study. Eur J Hum Genet 1998; 6:570.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/29\" class=\"nounderline abstract_t\">van Dorp DB. Albinism, or the NOACH syndrome (the book of Enoch c.v. 1-20). Clin Genet 1987; 31:228.</a></li><li class=\"breakAll\">Albinism, ocular, type I;OA1. In: Online Mendelian Inheritance in Man. Johns Hopkins University. www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300500 (Accessed on November 02, 2006).</li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/31\" class=\"nounderline abstract_t\">Shen B, Samaraweera P, Rosenberg B, Orlow SJ. Ocular albinism type 1: more than meets the eye. Pigment Cell Res 2001; 14:243.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/32\" class=\"nounderline abstract_t\">Oetting WS. New insights into ocular albinism type 1 (OA1): Mutations and polymorphisms of the OA1 gene. Hum Mutat 2002; 19:85.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/33\" class=\"nounderline abstract_t\">O'Donnell FE Jr, Green WR, Fleischman JA, Hambrick GW. X-linked ocular albinism in Blacks. Ocular albinism cum pigmento. Arch Ophthalmol 1978; 96:1189.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/34\" class=\"nounderline abstract_t\">Shiono T, Tsunoda M, Chida Y, et al. X linked ocular albinism in Japanese patients. Br J Ophthalmol 1995; 79:139.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/35\" class=\"nounderline abstract_t\">Lyle WM, Sangster JO, Williams TD. Albinism: an update and review of the literature. J Am Optom Assoc 1997; 68:623.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/36\" class=\"nounderline abstract_t\">Winship I, Gericke G, Beighton P. X-linked inheritance of ocular albinism with late-onset sensorineural deafness. Am J Med Genet 1984; 19:797.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/37\" class=\"nounderline abstract_t\">Winship IM, Babaya M, Ramesar RS. X-linked ocular albinism and sensorineural deafness: linkage to Xp22.3. Genomics 1993; 18:444.</a></li><li class=\"breakAll\">Albinism, ocular, with sensorineural deafness. In: Online Mendelian Inheritance in Man. Johns Hopkins University www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=103470 (Accessed on November 02, 2006).</li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/39\" class=\"nounderline abstract_t\">Spritz RA. Piebaldism, Waardenburg syndrome, and related disorders of melanocyte development. Semin Cutan Med Surg 1997; 16:15.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/40\" class=\"nounderline abstract_t\">Syrris P, Heathcote K, Carrozzo R, et al. Human piebaldism: six novel mutations of the proto-oncogene KIT. Hum Mutat 2002; 20:234.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/41\" class=\"nounderline abstract_t\">Dourmishev AL, Dourmishev LA, Schwartz RA, Janniger CK. Waardenburg syndrome. Int J Dermatol 1999; 38:656.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/42\" class=\"nounderline abstract_t\">Read AP, Newton VE. Waardenburg syndrome. J Med Genet 1997; 34:656.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/43\" class=\"nounderline abstract_t\">Nayak CS, Isaacson G. Worldwide distribution of Waardenburg syndrome. Ann Otol Rhinol Laryngol 2003; 112:817.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/44\" class=\"nounderline abstract_t\">Silan F, Zafer C, Onder I. Waardenburg syndrome in the Turkish deaf population. Genet Couns 2006; 17:41.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/45\" class=\"nounderline abstract_t\">Hart J, Miriyala K. Neural tube defects in Waardenburg syndrome: A case report and review of the literature. Am J Med Genet A 2017; 173:2472.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/46\" class=\"nounderline abstract_t\">Potterf SB, Furumura M, Dunn KJ, et al. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum Genet 2000; 107:1.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/47\" class=\"nounderline abstract_t\">Pingault V, Ente D, Dastot-Le Moal F, et al. Review and update of mutations causing Waardenburg syndrome. Hum Mutat 2010; 31:391.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/48\" class=\"nounderline abstract_t\">Edery P, Atti&eacute; T, Amiel J, et al. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet 1996; 12:442.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/49\" class=\"nounderline abstract_t\">McCallion AS, Chakravarti A. EDNRB/EDN3 and Hirschsprung disease type II. Pigment Cell Res 2001; 14:161.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/50\" class=\"nounderline abstract_t\">Pingault V, Bondurand N, Kuhlbrodt K, et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 1998; 18:171.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/51\" class=\"nounderline abstract_t\">Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997; 278:51.</a></li><li class=\"breakAll\">Hurwitz S. Clinical Pediatric Dermatology, 2nd ed, WB Saunders, Philadelphia 1993.</li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/53\" class=\"nounderline abstract_t\">Lim JY, Kim H, Kim YH, et al. Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway. Biochem Biophys Res Commun 2003; 302:238.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/54\" class=\"nounderline abstract_t\">Kwiatkowski DJ, Short MP. Tuberous sclerosis. Arch Dermatol 1994; 130:348.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/55\" class=\"nounderline abstract_t\">Webb DW, Clarke A, Fryer A, Osborne JP. The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol 1996; 135:1.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/56\" class=\"nounderline abstract_t\">Ringpfeil F, McGuigan K, Fuchsel L, et al. Pseudoxanthoma elasticum is a recessive disease characterized by compound heterozygosity. J Invest Dermatol 2006; 126:782.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/57\" class=\"nounderline abstract_t\">Le Saux O, Urban Z, Tschuch C, et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 2000; 25:223.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/58\" class=\"nounderline abstract_t\">Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci U S A 2000; 97:6001.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/59\" class=\"nounderline abstract_t\">Bergen AA, Plomp AS, Schuurman EJ, et al. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 2000; 25:228.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/60\" class=\"nounderline abstract_t\">Sherer DW, Sapadin AN, Lebwohl MG. Pseudoxanthoma elasticum: an update. Dermatology 1999; 199:3.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/61\" class=\"nounderline abstract_t\">Engelman MW, Fliegelman MT. Pseudoxanthoma elasticum. Cutis 1978; 21:837.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/62\" class=\"nounderline abstract_t\">Laube S, Moss C. Pseudoxanthoma elasticum. Arch Dis Child 2005; 90:754.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/63\" class=\"nounderline abstract_t\">Hardelin JP, Levilliers J, del Castillo I, et al. X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene. Proc Natl Acad Sci U S A 1992; 89:8190.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/64\" class=\"nounderline abstract_t\">Happle R. X-linked dominant chondrodysplasia punctata. Review of literature and report of a case. Hum Genet 1979; 53:65.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/65\" class=\"nounderline abstract_t\">Swinney CC, Han DP, Karth PA. Incontinentia Pigmenti: A Comprehensive Review and Update. Ophthalmic Surg Lasers Imaging Retina 2015; 46:650.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/66\" class=\"nounderline abstract_t\">Narayanan MJ, Rangasamy S, Narayanan V. Incontinentia pigmenti (Bloch-Sulzberger syndrome). Handb Clin Neurol 2015; 132:271.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/67\" class=\"nounderline abstract_t\">Aradhya S, Woffendin H, Jakins T, et al. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet 2001; 10:2171.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/68\" class=\"nounderline abstract_t\">Moore DJ, Mallory SB. Goltz syndrome. Pediatr Dermatol 1989; 6:251.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/69\" class=\"nounderline abstract_t\">Goltz RW. Focal dermal hypoplasia syndrome. An update. Arch Dermatol 1992; 128:1108.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/70\" class=\"nounderline abstract_t\">Grzeschik KH, Bornholdt D, Oeffner F, et al. Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. Nat Genet 2007; 39:833.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/71\" class=\"nounderline abstract_t\">Wang X, Reid Sutton V, Omar Peraza-Llanes J, et al. Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia. Nat Genet 2007; 39:836.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/72\" class=\"nounderline abstract_t\">Smahi A, Courtois G, Rabia SH, et al. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet 2002; 11:2371.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/73\" class=\"nounderline abstract_t\">Carrol ED, Gennery AR, Flood TJ, et al. Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO. Arch Dis Child 2003; 88:340.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/74\" class=\"nounderline abstract_t\">Lind LK, Stecks&eacute;n-Blicks C, Lejon K, Schmitt-Egenolf M. EDAR mutation in autosomal dominant hypohidrotic ectodermal dysplasia in two Swedish families. BMC Med Genet 2006; 7:80.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/75\" class=\"nounderline abstract_t\">Motil KJ, Fete TJ, Fraley JK, et al. Growth characteristics of children with ectodermal dysplasia syndromes. Pediatrics 2005; 116:e229.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/76\" class=\"nounderline abstract_t\">Masse JF, P&eacute;russe R. Ectodermal dysplasia. Arch Dis Child 1994; 71:1.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/77\" class=\"nounderline abstract_t\">Zhang XJ, Chen JJ, Yang S, et al. A mutation in the connexin 30 gene in Chinese Han patients with hidrotic ectodermal dysplasia. J Dermatol Sci 2003; 32:11.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/78\" class=\"nounderline abstract_t\">Common JE, Becker D, Di WL, et al. Functional studies of human skin disease- and deafness-associated connexin 30 mutations. Biochem Biophys Res Commun 2002; 298:651.</a></li><li><a href=\"https://www.uptodate.com/contents/the-genodermatoses/abstract/79\" class=\"nounderline abstract_t\">Chitty LS, Dennis N, Baraitser M. Hidrotic ectodermal dysplasia of hair, teeth, and nails: case reports and review. J Med Genet 1996; 33:707.</a></li><li class=\"breakAll\">Sutton VR. Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate Syndrome. In: GeneReviews [Internet], Pagon RA, Bird TD, Dolan CR, et al. (Eds), University of Washington, Seattle, Seattle; 1993-.</li></ol></div><div id=\"topicVersionRevision\">Topic 3004 Version 26.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H5358994\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H523750729\" id=\"outline-link-H523750729\">OVERVIEW</a></li><li><a href=\"#H523750890\" id=\"outline-link-H523750890\">DISORDERS WITH MALIGNANT POTENTIAL</a><ul><li><a href=\"#H523750943\" id=\"outline-link-H523750943\">Basal cell nevus syndrome</a></li><li><a href=\"#H523750950\" id=\"outline-link-H523750950\">Gardner syndrome</a></li><li><a href=\"#H523750957\" id=\"outline-link-H523750957\">Peutz-Jeghers syndrome</a></li><li><a href=\"#H523750964\" id=\"outline-link-H523750964\">Xeroderma pigmentosum</a></li><li><a href=\"#H523750971\" id=\"outline-link-H523750971\">Epidermolysis bullosa</a></li></ul></li><li><a href=\"#H2\" id=\"outline-link-H2\">DISORDERS OF KERATINIZATION</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Ichthyoses</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Palmoplantar keratodermas</a></li><li><a href=\"#H3247114\" id=\"outline-link-H3247114\">Pachyonychia congenita</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Darier disease</a></li></ul></li><li><a href=\"#H12\" id=\"outline-link-H12\">GENETIC BLISTERING DISORDERS</a><ul><li><a href=\"#H13\" id=\"outline-link-H13\">Epidermolysis bullosa</a></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">PIGMENTATION DISORDERS</a><ul><li><a href=\"#H19\" id=\"outline-link-H19\">Oculocutaneous albinism</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Ocular albinism</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">Piebaldism</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">Waardenburg syndrome</a></li></ul></li><li><a href=\"#H29839266\" id=\"outline-link-H29839266\">NEUROCUTANEOUS SYNDROMES</a><ul><li><a href=\"#H26\" id=\"outline-link-H26\">Neurofibromatosis type 1</a></li><li><a href=\"#H27\" id=\"outline-link-H27\">Neurofibromatosis type 2</a></li><li><a href=\"#H28\" id=\"outline-link-H28\">Tuberous sclerosis complex</a></li><li><a href=\"#H30\" id=\"outline-link-H30\">Ataxia-telangiectasia</a></li></ul></li><li><a href=\"#H29839329\" id=\"outline-link-H29839329\">VASCULAR DISORDERS</a></li><li><a href=\"#H32\" id=\"outline-link-H32\">DISORDERS OF CONNECTIVE TISSUE</a><ul><li><a href=\"#H33\" id=\"outline-link-H33\">Pseudoxanthoma elasticum</a></li></ul></li><li><a href=\"#H29839606\" id=\"outline-link-H29839606\">X-LINKED DOMINANT DISORDERS</a><ul><li><a href=\"#H29839499\" id=\"outline-link-H29839499\">Incontinentia pigmenti</a></li><li><a href=\"#H34\" id=\"outline-link-H34\">Focal dermal hypoplasia</a></li></ul></li><li><a href=\"#H35\" id=\"outline-link-H35\">ECTODERMAL DYSPLASIAS</a><ul><li><a href=\"#H36\" id=\"outline-link-H36\">Anhidrotic ectodermal dysplasia</a></li><li><a href=\"#H37\" id=\"outline-link-H37\">Hypohidrotic ectodermal dysplasia with immunodeficiency</a></li><li><a href=\"#H38\" id=\"outline-link-H38\">Hidrotic ectodermal dysplasia</a></li><li><a href=\"#H39\" id=\"outline-link-H39\">Ankyloblepharon-ectodermal defects-cleft lip/palate</a></li></ul></li><li><a href=\"#H5358994\" id=\"outline-link-H5358994\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/3004|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ONC/72687\" class=\"graphic graphic_picture\">- Palmar pits basal cell carcinoma nevus syndrome</a></li><li><a href=\"image.htm?imageKey=GAST/80815\" class=\"graphic graphic_picture\">- Peutz-Jeghers oral lesions</a></li><li><a href=\"image.htm?imageKey=DERM/52261\" class=\"graphic graphic_picture\">- Pachyonychia congenita - nails</a></li><li><a href=\"image.htm?imageKey=DERM/56168\" class=\"graphic graphic_picture\">- Darier disease - light skin</a></li><li><a href=\"image.htm?imageKey=DERM/70000\" class=\"graphic graphic_picture\">- Darier disease - dark skin</a></li><li><a href=\"image.htm?imageKey=DERM/81865\" class=\"graphic graphic_picture\">- Darier disease - nails</a></li><li><a href=\"image.htm?imageKey=DERM/58857\" class=\"graphic graphic_picture\">- Piebaldism</a></li><li><a href=\"image.htm?imageKey=DERM/52591\" class=\"graphic graphic_picture\">- Piebaldism - forelock</a></li><li><a href=\"image.htm?imageKey=DERM/71514\" class=\"graphic graphic_picture\">- Piebaldism - trunk and extremities</a></li><li><a href=\"image.htm?imageKey=PEDS/56776\" class=\"graphic graphic_picture\">- Waardenburg syndrome</a></li><li><a href=\"image.htm?imageKey=PEDS/69606\" class=\"graphic graphic_picture\">- Neurofibromata and cafe-au-lait macules</a></li><li><a href=\"image.htm?imageKey=DERM/82613\" class=\"graphic graphic_picture\">- Multiple neurofibromas</a></li><li><a href=\"image.htm?imageKey=DERM/67532\" class=\"graphic graphic_picture\">- Axillary freckling</a></li><li><a href=\"image.htm?imageKey=PEDS/61601\" class=\"graphic graphic_picture\">- TSC hypomelanotic macule</a></li><li><a href=\"image.htm?imageKey=PEDS/54868\" class=\"graphic graphic_picture\">- TSC angiofibromas</a></li><li><a href=\"image.htm?imageKey=PEDS/78688\" class=\"graphic graphic_picture\">- TSC forehead plaque</a></li><li><a href=\"image.htm?imageKey=DERM/80952\" class=\"graphic graphic_picture\">- Pseudoxanthoma elasticum neck 1</a></li><li><a href=\"image.htm?imageKey=DERM/59135\" class=\"graphic graphic_picture\">- Pseudoxanthoma elasticum neck 2</a></li><li><a href=\"image.htm?imageKey=DERM/70421\" class=\"graphic graphic_picture\">- Pseudoxanthoma elasticum lip</a></li><li><a href=\"image.htm?imageKey=DERM/76225\" class=\"graphic graphic_picture\">- PXE neck</a></li><li><a href=\"image.htm?imageKey=DERM/77863\" class=\"graphic graphic_picture\">- Angioid streaks</a></li><li><a href=\"image.htm?imageKey=DERM/55714\" class=\"graphic graphic_picture\">- Focal dermal hypoplasia</a></li><li><a href=\"image.htm?imageKey=DERM/80851\" class=\"graphic graphic_picture\">- Anhidrotic ectodermal dysplasia</a></li><li><a href=\"image.htm?imageKey=DERM/66563\" class=\"graphic graphic_picture\">- Anhidrotic ectodermal dysplasia - teeth</a></li><li><a href=\"image.htm?imageKey=DERM/61258\" class=\"graphic graphic_picture\">- Ichthyosis vulgaris 2</a></li><li><a href=\"image.htm?imageKey=PEDS/66723\" class=\"graphic graphic_picture\">- X-linked ichthyosis</a></li><li><a href=\"image.htm?imageKey=PEDS/59842\" class=\"graphic graphic_picture\">- Lamellar ichthyosis</a></li><li><a href=\"image.htm?imageKey=DERM/59364\" class=\"graphic graphic_picture\">- Epidermolysis bullosa simplex - hands</a></li><li><a href=\"image.htm?imageKey=DERM/73201\" class=\"graphic graphic_picture\">- Epidermolysis bullosa simplex - feet</a></li><li><a href=\"image.htm?imageKey=DERM/58769\" class=\"graphic graphic_picture\">- Incontinentia pigmenti</a></li></ul></li><li><div id=\"DERM/3004|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/72060\" class=\"graphic graphic_table\">- Genodermatoses and malignancy</a></li><li><a href=\"image.htm?imageKey=PEDS/71157\" class=\"graphic graphic_table\">- Ichthyoses</a></li><li><a href=\"image.htm?imageKey=PEDS/76897\" class=\"graphic graphic_table\">- Epidermolysis bullosa</a></li><li><a href=\"image.htm?imageKey=DERM/77709\" class=\"graphic graphic_table\">- Epidermolysis bullosa simplex variants</a></li><li><a href=\"image.htm?imageKey=DERM/67202\" class=\"graphic graphic_table\">- Junctional epidermolysis bullosa variants</a></li><li><a href=\"image.htm?imageKey=DERM/55262\" class=\"graphic graphic_table\">- Dystrophic epidermolysis bullosa variants</a></li><li><a href=\"image.htm?imageKey=DERM/81536\" class=\"graphic graphic_table\">- Kindler syndrome 2</a></li><li><a href=\"image.htm?imageKey=DERM/115427\" class=\"graphic graphic_table\">- Oculocutaneous albinism genetic classification</a></li><li><a href=\"image.htm?imageKey=DERM/70579\" class=\"graphic graphic_table\">- Albinism classification</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=ataxia-telangiectasia\" class=\"medical medical_review\">Ataxia-telangiectasia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-ehlers-danlos-syndromes\" class=\"medical medical_review\">Clinical manifestations and diagnosis of Ehlers-Danlos syndromes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-syndrome\" class=\"medical medical_review\">Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=combined-immunodeficiencies\" class=\"medical medical_review\">Combined immunodeficiencies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-aganglionic-megacolon-hirschsprung-disease\" class=\"medical medical_review\">Congenital aganglionic megacolon (Hirschsprung disease)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=darier-disease\" class=\"medical medical_review\">Darier disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-epidermolysis-bullosa\" class=\"medical medical_review\">Diagnosis of epidermolysis bullosa</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-risk-factors-for-cutaneous-squamous-cell-carcinoma\" class=\"medical medical_review\">Epidemiology and risk factors for cutaneous squamous cell carcinoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-pathogenesis-and-clinical-features-of-basal-cell-carcinoma\" class=\"medical medical_review\">Epidemiology, pathogenesis, and clinical features of basal cell carcinoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-pathogenesis-classification-and-clinical-features-of-epidermolysis-bullosa\" class=\"medical medical_review\">Epidemiology, pathogenesis, classification, and clinical features of epidermolysis bullosa</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gardner-syndrome\" class=\"medical medical_review\">Gardner syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=genetics-clinical-features-and-diagnosis-of-marfan-syndrome-and-related-disorders\" class=\"medical medical_review\">Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=incontinentia-pigmenti\" class=\"medical medical_review\">Incontinentia pigmenti</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=keratinopathic-ichthyoses\" class=\"medical medical_review\">Keratinopathic ichthyoses</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-marfan-syndrome-and-related-disorders\" class=\"medical medical_review\">Management of Marfan syndrome and related disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=netherton-syndrome\" class=\"medical medical_review\">Netherton syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neurofibromatosis-type-1-nf1-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neurofibromatosis-type-2\" class=\"medical medical_review\">Neurofibromatosis type 2</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neuropathies-associated-with-hereditary-disorders\" class=\"medical medical_review\">Neuropathies associated with hereditary disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nevoid-basal-cell-carcinoma-syndrome\" class=\"medical medical_review\">Nevoid basal cell carcinoma syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=oculocutaneous-albinism\" class=\"medical medical_review\">Oculocutaneous albinism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=osteogenesis-imperfecta-clinical-features-and-diagnosis\" class=\"medical medical_review\">Osteogenesis imperfecta: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=osteogenesis-imperfecta-management-and-prognosis\" class=\"medical medical_review\">Osteogenesis imperfecta: Management and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-and-classification-of-the-inherited-ichthyoses\" class=\"medical medical_review\">Overview and classification of the inherited ichthyoses</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-management-of-ehlers-danlos-syndromes\" class=\"medical medical_review\">Overview of the management of Ehlers-Danlos syndromes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-management-of-epidermolysis-bullosa\" class=\"medical medical_review\">Overview of the management of epidermolysis bullosa</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=paronychia\" class=\"medical medical_review\">Paronychia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=peutz-jeghers-syndrome-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Peutz-Jeghers syndrome: Epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=recessive-x-linked-ichthyosis\" class=\"medical medical_review\">Recessive X-linked ichthyosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sjogren-larsson-syndrome\" class=\"medical medical_review\">Sj&ouml;gren-Larsson syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tuberous-sclerosis-complex-genetics-clinical-features-and-diagnosis\" class=\"medical medical_review\">Tuberous sclerosis complex: Genetics, clinical features, and diagnosis</a></li></ul></div></div>","javascript":null}